Silent corticotroph adenomas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 8, 2007, Pages 1314-1318

  Karavitaki, Niki ^a   Ansorge, Olaf ^b   Wass, John A H ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Silent corticotroph adenomas

Indexed keywords

EID: 38649104154     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302007000800017     Document Type: Review

References (27)

1. Kovacs K, Horvath E, Bayley TA, Hassaram ST, Ezrin C. Silent corticotroph cell adenoma with lysosomal accumulation and crinophagy. A distinct clinicopathologic entity. Am J Med 1978;64:492-9.
2. Horvath E, Kovacs K, Killinger DW, Smyth HS, Platts ME, Singer W. Silent corticotropic adenomas of the human pituitary gland: a histologic, immunocytologic, and ultrastructural study. Am J Pathol 1980;98:617-38.
3. Roncaroli F, Scheithauer BW, Young WF, Horvath E, Kovacs K, Kros JM, et al. Silent corticotroph carcinoma of the adenohypophysis: a report of five cases. Am J Surg Pathol 2003;27:477-86.
4. Sahli R, Christ ER, Seiler R, Kappeler A, Vajtai I. Clinicopathologic correlations of silent corticotroph adenomas of the pituitary: report of four cases and literature review. Pathol Res Pract 2006;202:457-64.
5. Baldeweg SE, Pollock JR, Powell M, Ahlquist J. A spectrum of behaviour in silent corticotroph pituitary adenomas. Br J Neurosurg 2005;19:38-42.
6. Lopez JA, Kleinschmidt-Demasters Bk B, Sze CI, Woodmansee WW, Lillehei KO. Silent corticotroph adenomas: further clinical and pathological observations. Hum Pathol 2004;35:1137-47.
7. Webb MK, Laurent JJ, Okonkwo DO, Lopes MB, Vance ML, Laws ER. Clinical characteristics of silent corticotrophic adenomas and creation of an internet-accessible database to facilitate their multi-institutional study. Neurosurgery 2003;53:1076-108.
8. Scheithauer BW, Jaap AJ, Horvath E, Kovacs K, Lloyd RV, Meyer FB, et al. Clinically silent corticotroph tumors of the pituitary gland. Neurosurgery 2000;47:723-9.
9. Thapar K, Horvath E, Kovacs K. Neoplasms of the sellar region. In: McLendon RE, Rosenblum MK, Bigner DD (eds). Russell and Rubinstein's Pathology of Tumors of the Nervous System. London: Hodder Arnold, 2006. pp. 663-764.
10. Roncaroli F, Faustini-Fustini M, Mauri F, Asioli S, Frank G. Crooke's hyalinization in silent corticotroph adenoma: report of two cases. Endocr Pathol 2002;13:245-9.
11. Horvath E, Kovacs K, Lloyd R. Pars intermedia of the human pituitary revisited: Morphologic aspects and frequency of hyperplasia of POMC peptide immunoreactive cells. Endocr Pathol 1999;101:55-64.
12. Vallette-Kasic S, Figarella-Branger D, Grino M, Pulichino AM, Dufour H, Grisoli F, et al. Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs. J Clin Endocrinol Metab 2003;88:3050-6.
13. Jin L, Riss D, Ruebel K, Kajita S, Scheithauer BW, Horvath E, et al. Galectin-3 expression in functioning and silent ACTHproducing adenomas. Endocr Pathol 2005;16:107-14.
14. Thodou E, Argyrakos T, Kontogeorgos G. Galectin-3 as a marker distinguishing functioning from silent corticotroph adenomas. Hormones (Athens) 2007;6:227-32.
15. Reincke M, Allolio B, Saeger W, Kaulen D, Winkelmann W. A pituitary adenoma secreting high molecular weight adrenocorticotropin without evidence of Cushing's disease. J Clin Endocrinol Metab 1987;65:1296-300.
16. Nagaya T, Seo H, Kuwayama A, Sakurai T, Tsukamoto N, et al. Pro-opiomelanocortin gene expression in silent corticotroph-cell adenoma and Cushing's disease. J Neurosurg 1990;72:262-7.
17. Braithwaite SS, Clasen RA, D'Angelo CM. Silent corticotroph adenoma: case report and literature review. Endocr Pract 1997;3:297-301.
18. Ohta S, Nishizawa S, Oki Y, Yokoyama T, Namba H. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I - immunohistochemical study. Pituitary 2002;5:221-3.
19. Bradley KJ, Wass JA, Turner HE. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently. Clin Endocrinol (Oxf) 2003;58:59-64.
20. Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, et al. Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 2006;59:341-53.
21. Gogel EL, Salber PR, Tyrrell JB, Rosenblum ML, Findling JW. Cushing's disease in a patient with a 'nonfunctioning' pituitary tumor. Spontaneous development and remission. Arch Intern Med 1983;143:1040-2.
22. Vaughan NJ, Laroche CM, Goodman I, Davies MJ, Jenkins JS. Pituitary Cushing's disease arising from a previously nonfunctional corticotrophic chromophobe adenoma. Clin Endocrinol (Oxf) 1985; 22:147-53.
23. Cooper ME, Murray RM, Kalnins R, Woodward J, Jerums G. The development of Cushing's syndrome from a previously silent pituitary tumour. Aust N Z J Med 1987;17:249-51.
24. Lloyd RV, Fields K, Jin L, Horvath E, Kovacs K. Analysis of endocrine active and clinically silent corticotropic adenomas by in situ hybridization. Am J Pathol 1990;137:479-88.
25. Farrell WE, Coll AP, Clayton RN, Harris PE. Corticotroph carcinoma presenting as a silent corticotroph adenoma. Pituitary 2003;6:41-7.
26. George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF Jr, Lloyd RV, et al. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. Am J Surg Pathol 2003;27:1330-6.
27. Petrossians P, Ronci N, Valdés Socin H, Kalife A, Stevenaert A, Bloch B, et al. ACTH silent adenoma shrinking under cabergoline. Eur J Endocrinol 2001;144:51-7.